Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Resource Type
Article
Authors
James, Nicholas D ; Sydes, Matthew R ; Clarke, Noel W ; Mason, Malcolm D ; Dearnaley, David P ; Spears, Melissa R ; Ritchie, Alastair W S ; Parker, Christopher C ; Russell, J Martin ; Attard, Gerhardt ; de Bono, Johann ; Cross, William ; Jones, Rob J ; Thalmann, George ; Amos, Claire ; Matheson, David ; Millman, Robin ; Alzouebi, Mymoona ; Beesley, Sharon ; Birtle, Alison J ; Brock, Susannah ; Cathomas, Richard ; Chakraborti, Prabir ; Chowdhury, Simon ; Cook, Audrey ; Elliott, Tony ; Gale, Joanna ; Gibbs, Stephanie ; Graham, John D ; Hetherington, John ; Hughes, Robert ; Laing, Robert ; McKinna, Fiona ; McLaren, Duncan B ; O'Sullivan, Joe M ; Parikh, Omi ; Peedell, Clive ; Protheroe, Andrew ; Robinson, Angus J ; Srihari, Narayanan ; Srinivasan, Rajaguru ; Staffurth, John ; Sundar, Santhanam ; Tolan, Shaun ; Tsang, David ; Wagstaff, John ; Parmar, Mahesh K B
Source
In The Lancet 19-25 March 2016 387(10024):1163-1177
Subject
Primary Research Articles
Language
ISSN
0140-6736